Compare ELAN & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELAN | COO |
|---|---|---|
| Founded | 1954 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 13.6B |
| IPO Year | 2018 | 1994 |
| Metric | ELAN | COO |
|---|---|---|
| Price | $26.29 | $60.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 17 |
| Target Price | $31.15 | ★ $65.80 |
| AVG Volume (30 Days) | ★ 4.7M | 2.2M |
| Earning Date | 11-06-2026 | 12-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.26 | ★ 2.49 |
| Revenue | ★ $4,715,000,000.00 | $2,532,800,000.00 |
| Revenue This Year | $10.10 | $3.58 |
| Revenue Next Year | $4.97 | $4.02 |
| P/E Ratio | $101.08 | ★ $24.19 |
| Revenue Growth | 6.22 | ★ 18.41 |
| 52 Week Low | $19.40 | $51.01 |
| 52 Week High | $27.98 | $89.83 |
| Indicator | ELAN | COO |
|---|---|---|
| Relative Strength Index (RSI) | 61.36 | 46.51 |
| Support Level | $22.12 | $59.02 |
| Resistance Level | $27.66 | $62.71 |
| Average True Range (ATR) | 1.10 | 1.53 |
| MACD | 0.10 | -0.32 |
| Stochastic Oscillator | 74.64 | 13.80 |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.